Class II

Drug Recall: Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.

Imprimis NJOF, LLC · December 18, 2025

Reason for Recall

Presence of particulate matter - Glass like particles.

Distribution

U.S Nationwide

States Affected

NATIONWIDE

Quantity Affected

314 boxes of 6,280 pre-filled syringes

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0251-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.